Literature DB >> 21713533

Primary transpupillary thermotherapy for small choroidal melanoma.

Martha Motono Chojniak1, Rubens Chojniak, Ines Nobuko Nishimoto, Norma Allemann, Clélia Maria Erwenne.   

Abstract

BACKGROUND: The treatment of small choroidal melanoma is controversial. Thermal laser-induced treatment is utilized by some centers but there is still sparse literature about the subject, mainly with short-term follow-up time. The efficacy of transpupillary thermotherapy (TTT) for the treatment of small choroidal melanomas was evaluated.
METHODS: A prospective nonrandomized study of transpupillary thermotherapy for small (thickness ≤ 4.0 mm and basal diameter ≤ 12 mm) pigmented choroidal melanomas presenting either growth or risk factors for growth and metastasis. Ophthalmoscopic aspect, tumor control, visual acuity and complications were evaluated.
RESULTS: Twenty-seven patients were treated; mean age 61 years; mean tumor thickness before treatment was 2.7 mm and base was 8.52 mm. After a mean of three treatment sessions and 45-month follow-up, mean tumor thickness decreased significantly to 1.34 mm (p < 0.001) and mean tumor base to 5.48 mm (p < 0.001). Complications were observed in 12 patients (44%) and included retinal vascular occlusion, optic disc atrophy, retinal traction, vitreous hemorrhage, rhegmatogenous retinal detachment, and maculopathy. Lesions touching the optic disc were associated with a significantly higher rate of disc atrophy after treatment (60% vs. 40%, p=0.030). Visual acuity remained the same in nine eyes (33%), improved in five (19%) and decreased during the first 6 months after treatment in 13 eyes (48%). Complete tumor control without recurrence was observed in 25 patients (93%). Recurrence at tumor margin was detected in two (7%). All eyes were preserved. One patient had tumor-related death.
CONCLUSIONS: TTT is an effective treatment in the management of selected small choroidal melanoma. Decrease in visual acuity occurred early after treatment mainly associated with subfoveal and perifoveal tumors treatment and complications. Long-term randomized studies are still needed in order to better situate this treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713533     DOI: 10.1007/s00417-011-1733-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

1.  Tumor destruction by intermediate level hyperthermia.

Authors:  E M Nuijs-Beems; J A Oosterhuis; E H Verburg-van der Marel; D de Wolff-Rouendaal; J L van Delft; J A van Best
Journal:  Curr Eye Res       Date:  1990-08       Impact factor: 2.424

2.  Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1997-12

3.  Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.

Authors:  K M Egan; L M Ryan; E S Gragoudas
Journal:  Arch Ophthalmol       Date:  1998-03

4.  Proper method for calculating average visual acuity.

Authors:  J T Holladay
Journal:  J Refract Surg       Date:  1997 Jul-Aug       Impact factor: 3.573

5.  Primary transpupillary thermotherapy for small choroidal melanomas.

Authors:  Y Pan; K Diddie; J I Lim
Journal:  Br J Ophthalmol       Date:  2007-11-02       Impact factor: 4.638

6.  Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma.

Authors:  T M Aaberg; C S Bergstrom; Z J Hickner; M J Lynn
Journal:  Br J Ophthalmol       Date:  2008-02-22       Impact factor: 4.638

Review 7.  Tumour microcirculation as a target for hyperthermia.

Authors:  H S Reinhold; B Endrich
Journal:  Int J Hyperthermia       Date:  1986 Apr-Jun       Impact factor: 3.914

8.  Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma.

Authors:  J G Journée-de Korver; J A Oosterhuis; H M Kakebeeke-Kemme; D de Wolff-Rouendaal
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

9.  Retinal break and rhegmatogenous retinal detachment after transpupillary thermotherapy as primary or adjunct treatment of choroidal melanoma.

Authors:  Arman Mashayekhi; Carol L Shields; Sung Chul Lee; Brian P Marr; Jerry A Shields
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

10.  Long-term outcome of transpupillary thermotherapy as primary treatment of selected choroidal melanoma.

Authors:  Raffaele Parrozzani; Barbara Boccassini; Valentina De Belvis; Pietro Paolo Radin; Edoardo Midena
Journal:  Acta Ophthalmol       Date:  2008-09-05       Impact factor: 3.761

View more
  1 in total

Review 1.  The effect of intravitreal bevacizumab and transpupillary thermotherapy on choroidal metastases and literature review.

Authors:  Chun-Ju Lin; Yi-Yu Tsai
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.